Advertisement

Topics

Zogenix shares pop on impressive Phase 3 results for epilepsy drug

04:21 EDT 12 Jul 2018 | Proactive Investors

The biotech's experimental drug ZX008 reduced the frequency of convulsive seizures in Phase 3 trial

Original Article: Zogenix shares pop on impressive Phase 3 results for epilepsy drug

NEXT ARTICLE

More From BioPortfolio on "Zogenix shares pop on impressive Phase 3 results for epilepsy drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...